Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,067Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Nesina

02 1Nesina/Vipidia-F *2

PharmaCompass

01

Brand Name : Nesina

Alogliptin

arrow
Medlab Asia & Asia Health
Not Confirmed

02

Brand Name : Nesina

Alogliptin

arrow
Medlab Asia & Asia Health
Not Confirmed

03

Brand Name : Nesina/Vipidia-F *2

Alogliptin

arrow
Medlab Asia & Asia Health
Not Confirmed

Brand Name : Nesina/Vipidia-F *2

arrow
Medlab Asia & Asia Health
Not Confirmed

Alogliptin

Main Therapeutic Indication : Endocrinology

Currency : USD

2021 Revenue in Millions : 111

2020 Revenue in Millions : 532

Growth (%) : -78

blank

04

Brand Name : Nesina

Alogliptin Benzoate

arrow
Medlab Asia & Asia Health
Not Confirmed

05

Brand Name : Nesina

Alogliptin Benzoate

arrow
Medlab Asia & Asia Health
Not Confirmed

06

Brand Name : Nesina

Alogliptin Benzoate

arrow
Medlab Asia & Asia Health
Not Confirmed